Notes
Notes - notes.io |
NMN (Nicotinamide Mononucleotide),
36kr learned today that the international academic journal aging published an article on policies for the protection and adjustment of the elderly to reduce comorbidity, infection rate, severity and mortality of neutrophil and neutrophil infection. The research publisher is the biotherapy research foundation, a British charity that has supported and promoted world research on aging and longevity since 2008. According to Scimago, aging is the top five academic journal in the field of longevity research.
There is still a long way to go in clinical practice. For the elderly, the treatment effect may decline. A recent BBC report pointed out: "the pneumonia vaccine caused by the new crown may not have much impact on the elderly. It is not the fault of the vaccine itself, but because the aging immune system is unable to respond to immunity. We see this situation every year when we are vaccinated against influenza."
Zhavoronkov also proposed strategies to prevent new COVID-19 infections through repeated use of known safety drugs such as rapamycin, nicotinose ribose, nicotinamide mononucleotide and metformin. The scientist analyzed the clinical studies in the healthy elderly before Rad001 and the previous evidence of abnormal immune enhancement of rapamycin, and proposed clinical trials.
He also recommends tracking the effectiveness of this preventive elderly protection intervention and classifying patients according to the predicted new crown severity.
"We are integrating artificial intelligence into the drug discovery platform we are testing to find solutions for drug discovery and drug reuse. However, some studies have shown that the new crown is a neutrophilic disease, which is more serious and fatal for the elderly," said Dr. Alex zavoronkov. "The results of aging research help to prevent not only new crowns, but also many other diseases`
Read More: https://www.esthelivsale.com/products-uniqueness
|
|
Notes.io is a web-based application for taking notes. You can take your notes and share with others people. If you like taking long notes, notes.io is designed for you. To date, over 8,000,000,000 notes created and continuing...
With notes.io;
- * You can take a note from anywhere and any device with internet connection.
- * You can share the notes in social platforms (YouTube, Facebook, Twitter, instagram etc.).
- * You can quickly share your contents without website, blog and e-mail.
- * You don't need to create any Account to share a note. As you wish you can use quick, easy and best shortened notes with sms, websites, e-mail, or messaging services (WhatsApp, iMessage, Telegram, Signal).
- * Notes.io has fabulous infrastructure design for a short link and allows you to share the note as an easy and understandable link.
Fast: Notes.io is built for speed and performance. You can take a notes quickly and browse your archive.
Easy: Notes.io doesn’t require installation. Just write and share note!
Short: Notes.io’s url just 8 character. You’ll get shorten link of your note when you want to share. (Ex: notes.io/q )
Free: Notes.io works for 12 years and has been free since the day it was started.
You immediately create your first note and start sharing with the ones you wish. If you want to contact us, you can use the following communication channels;
Email: [email protected]
Twitter: http://twitter.com/notesio
Instagram: http://instagram.com/notes.io
Facebook: http://facebook.com/notesio
Regards;
Notes.io Team
